DOHA: A medical textbook, Handbook of Clinical Neurology to serve as a comprehensive guide for clinicians and researchers dealing with complications of the nervous system arising from diabetes has been co-edited by Weill Cornell Medical College in Qatar (WCMC-Q) Researcher Dr Rayaz Malik.
Dr Malik, Professor of Medicine, edited the 640-page book, Diabetes and the Nervous System: Handbook of Clinical Neurology with Dr Douglas Zochodne, Professor of Neurology, University of Alberta.
The handbook, which took three years to compile, comprises 36 chapters written by the world’s foremost experts in the field of diabetic neuropathy from elite institutions in North America, Europe, New Zealand, Japan and Qatar.
It provides a comprehensive update on experimental and translational studies of the peripheral and central nervous system in children and adults with diabetes and pre-diabetes.
Latest diagnostic techniques including peripheral and central imaging and therapies for diabetic neuropathy are discussed in detail.
Dr Malik said, “Our aim with the handbook is to provide a comprehensive and up-to-date guide for clinicians and researchers to help bridge the translational gap towards earlier diagnosis and treatment with the best therapies to improve patient outcomes.
“Overall, the handbook shows there is a lot of research going on in the field of diabetic neuropathy and highlights roadblocks and difficulties researchers have encountered.
“This knowledge will hopefully be a useful guide to researchers working towards the development of an effective new therapy for diabetic neuropathy.
“The global diabetes and obesity epidemic means that diabetic neuropathy, which affects at least 50 percent of all diabetic patients, has become a pressing health issue for medical science and society at large.
“While researchers have been able to demonstrate the viability of experimental therapies in the laboratory, all have fallen by the wayside as there is no FDA-approved therapy for human diabetic neuropathy. This highlights the translational gap, which may be due to a lack of an ability to demonstrate therapeutic efficacy in humans, rather than a true lack of efficacy.
“Overall the handbook shows that there is a lot of research going on in the field of diabetic neuropathy, but also highlights the roadblocks and difficulties that researchers have encountered. This knowledge will hopefully be a useful guide to researchers working towards the development of an effective new therapy for diabetic neuropathy.”
Dr Khaled Machaca, Associate Dean, Research, WCMC-Q, said, “The handbook is a wonderful piece of scholarship that will serve as a useful practical aid for physicians treating diabetic neuropathy and investigators searching for viable new therapies for the condition, which can be distressing and debilitating for sufferers.”
The book is published by Elsevier Science and Technology.
The Peninsula
